The syringe’s patented technology, which has just received approval from the US Federal Drug Administration (FDA), features a unique pneumatic system of automatically retracting and disabling needles after a single use, setting new standards of performance and protection.
To coincide with Zephyrus’s FDA approval and subsequent international PR campaign, HTP were asked too develop a website and 3D animation sequence that would explain in less than a minute the syringe’s Aeroject™ technology, show it in action and at the same time provide background medical information.
In one short, dynamic sequence we clearly positioned Zephyrus as setting new safety standards and got across the Aeroject™ technique. Zephyrus is now in production and building up high levels of interest.